EcoR1 Capital’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.4M | Hold |
10,630,736
| – | – | 3.22% | 9 |
|
|
2025
Q1 | $14.6M | Hold |
10,630,736
| – | – | 0.86% | 21 |
|
|
2024
Q4 | $32.8M | Sell |
10,630,736
-2,700,000
| -20% | -$8.34M | 1.24% | 16 |
|
|
2024
Q3 | $103M | Hold |
13,330,736
| – | – | 3.51% | 10 |
|
|
2024
Q2 | $114M | Hold |
13,330,736
| – | – | 3.5% | 10 |
|
|
2024
Q1 | $106M | Hold |
13,330,736
| – | – | 2.68% | 13 |
|
|
2023
Q4 | $132M | Buy |
13,330,736
+4,609,100
| +53% | +$45.6M | 3.43% | 9 |
|
|
2023
Q3 | $98.2M | Buy |
8,721,636
+4,674,522
| +116% | +$52.6M | 3.31% | 10 |
|
|
2023
Q2 | $13.4M | Sell |
4,047,114
-154,300
| -4% | -$512K | 0.33% | 29 |
|
|
2023
Q1 | $16.6M | Hold |
4,201,414
| – | – | 0.53% | 30 |
|
|
2022
Q4 | $30.5M | Hold |
4,201,414
| – | – | 0.93% | 20 |
|
|
2022
Q3 | $15.2M | Buy |
4,201,414
+1,899,349
| +83% | +$6.88M | 0.45% | 30 |
|
|
2022
Q2 | $10.4M | Buy |
2,302,065
+1,540,094
| +202% | +$6.98M | 0.36% | 38 |
|
|
2022
Q1 | $5.78M | Sell |
761,971
-538,029
| -41% | -$4.08M | 0.18% | 48 |
|
|
2021
Q4 | $14.2M | Hold |
1,300,000
| – | – | 0.45% | 34 |
|
|
2021
Q3 | $16.8M | Buy |
1,300,000
+500,000
| +63% | +$6.47M | 0.58% | 26 |
|
|
2021
Q2 | $9.1M | Hold |
800,000
| – | – | 0.34% | 35 |
|
|
2021
Q1 | $8.9M | Hold |
800,000
| – | – | 0.39% | 33 |
|
|
2020
Q4 | $9.15M | Hold |
800,000
| – | – | 0.49% | 30 |
|
|
2020
Q3 | $8.29M | Buy |
+800,000
| New | +$8.29M | 0.59% | 24 |
|